Back to search

Article

Small RNA activation of CDH13 expression overcome BCR-ABL1-independent imatinib-resistance and their signaling pathway studies in chronic myeloid leukemia

2024-02-20

Abstract excerpt

<title>Abstract</title> <p>BCR-ABL1-independent resistance to imatinib has no effective treatment due to its complexity and diversity. We previously reported that the CDH13 oncogene was expressed at low levels in BCR-ABL1-independent resistant CML cell lines. However, its effects on CML resistant cells and mechanisms remain unknown. This study investigated the effects of saRNA-based CDH13 activation on BCR-ABL1-i...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8ebcd940-e7fa-5a06-ab74-7a9b4265a801
DOI
10.21203/rs.3.rs-3402305/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Small RNA activation of CDH13 expression overcome BCR-ABL1-independent imatinib-resistance and their signaling pathway studies in chronic myeloid leukemiaDOI 10.21203/rs.3.rs-3402305/v1
Select a neighboring publication to make it the new centre.